Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Viyash Scientific Merger & Restructuring

Viyash Scientific Limited announced receipt of Italian regulatory approval for its subsidiary Alivira Animal Health's acquisition of BioForLife Italia S.r.l. The transaction completion timeline is extended.

Source

BSE filing, NSE: VIYASH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Viyash Scientific Ltd: key numbers

Share price
₹220.31
Market cap
₹9,732 Cr
Revenue (annual)
₹3,420 Cr
Net profit (annual)
₹177.3 Cr
P/E (TTM)
56.9×Sector 45.9×
Promoter holding
49.24%-12.07% QoQ
FII holding
2.60%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Viyash Scientific Ltd

All →

Other merger & restructuring announcements

All →